116 related articles for article (PubMed ID: 7863634)
1. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome.
de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A
Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
Mathew P; Conley ME
Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
[TBL] [Abstract][Full Text] [Related]
4. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome.
Corash L; Shafer B; Blaese RM
Blood; 1985 Jun; 65(6):1439-43. PubMed ID: 3995178
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
7. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
Krisiukeniene A; Sitkauskiene B; Sakalauskas R
Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
[TBL] [Abstract][Full Text] [Related]
8. [Wiskott-Aldrich syndrome (literature review)].
Shabalov NP
Vopr Okhr Materin Det; 1975 Feb; 20(2):50-4. PubMed ID: 1094723
[No Abstract] [Full Text] [Related]
9. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.
Kawakami C; Miyake M; Tamai H
Int J Hematol; 2003 Feb; 77(2):199-200. PubMed ID: 12627860
[No Abstract] [Full Text] [Related]
10. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
Lum LG; Tubergen DG; Corash L; Blaese RM
N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
[TBL] [Abstract][Full Text] [Related]
11. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size.
Patel PD; Samanich JM; Mitchell WB; Manwani D
Pediatr Blood Cancer; 2011 Jul; 56(7):1127-9. PubMed ID: 21488158
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome.
Meuwissen HJ; Bortin MM; Bach FH; Porter IH; Schreinmachers D; Harrison BA; Taft E
J Pediatr; 1984 Sep; 105(3):365-9. PubMed ID: 6381679
[TBL] [Abstract][Full Text] [Related]
13. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
[TBL] [Abstract][Full Text] [Related]
14. A prenatal study of fetal platelet count and size with application to fetus at risk for Wiskott-Aldrich syndrome.
Holmberg L; Gustavii B; Jönsson A
J Pediatr; 1983 May; 102(5):773-6. PubMed ID: 6842338
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient.
Hongeng S; Pakakasama S; Hathirat P; Chaisiripoomkere W; Ungkanont A
Bone Marrow Transplant; 1999 Aug; 24(4):445-6. PubMed ID: 10467341
[No Abstract] [Full Text] [Related]
16. Neonatal Thrombocytopenia: Etiology and Diagnosis.
Sillers L; Van Slambrouck C; Lapping-Carr G
Pediatr Ann; 2015 Jul; 44(7):e175-80. PubMed ID: 26171707
[TBL] [Abstract][Full Text] [Related]
17. Descending aortic aneurysm in Wiskott-Aldrich syndrome: options for repair.
Wood G; Booth K; Khan Z; Biss T; Roysam C; Dark J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):635-637. PubMed ID: 29022827
[TBL] [Abstract][Full Text] [Related]
18. Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome.
Knutsen AP; Rosse WF; Kinney TR; Buckley RH
J Clin Immunol; 1981 Jan; 1(1):13-9. PubMed ID: 7334067
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of large-platelet counts in patients with immune thrombocytopenic purpura.
Michel M; Kreidel F; Chapman ES; Zelmanovic D; Bussel JB
Haematologica; 2005 Dec; 90(12):1715-6. PubMed ID: 16330456
[TBL] [Abstract][Full Text] [Related]
20. An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome.
Conley ME; Saragoussi D; Notarangelo L; Etzioni A; Casanova JL; ;
Clin Immunol; 2003 Dec; 109(3):272-7. PubMed ID: 14697741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
